Advertisement
Document › Details
IP Group plc. (5/4/21). "Press Release: Portfolio Company Oxford Nanopore Technologies Raises £195m in New Investment".
Organisation | IP Group plc (LSE: IPO) | |
Group | IP Group (Group) | |
Organisation 2 | Oxford Nanopore Technologies Ltd. | |
Today | Oxford Nanopore Technologies plc (LSE: ONT) | |
Group | Oxford Nanopore (Group) | |
Product | nanopore DNA sequencer | |
Product 2 | public equity | |
Index term | Oxford Nanopore–SEVERAL: investment, 202105 financing round £195m from new + existing investors | |
Person | Smith, Greg (IP Group 2022 CEO before CFO) | |
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that portfolio company Oxford Nanopore Technologies Ltd ("Oxford Nanopore") has raised £195 million in new capital including £125 million from new investors Temasek, Wellington Management, M&G Investments and Nikon with existing shareholders investing £70 million.
IP Group committed £18.7million to the round, being its full pre-emptive allocation. Following completion of the round, IP Group has a 14.5% undiluted beneficial stake in Oxford Nanopore, valued at £359 million.
For more information, please contact:
IP Group plc
www.ipgroupplc.com
Greg Smith, Chief Financial Officer
Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0050
+44 (0) 20 7444 0062/+44 (0) 7979 853802
Charlotte Street Partners
David Gaffney
+44 (0) 7854 609998
Andrew Wilson
+44 (0) 7810 636995
Notes for editors
About IP Group
IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.
For more information, please visit our website at www.ipgroupplc.com.
Record changed: 2023-06-05 |
Advertisement
More documents for IP Group (Group)
- [1] Mogrify Ltd.. (5/4/21). "Press Release: Mogrify Completes Series A financing Totaling $33 Million USD". Cambridge....
- [2] Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford....
- [3] IP Group plc. (5/15/18). "Press Release: IP Group and Johns Hopkins Collaboration Funds Cancer Therapeutic Start-up"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top